» Articles » PMID: 24167195

A DNMT3A Mutation Common in AML Exhibits Dominant-negative Effects in Murine ES Cells

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2013 Oct 30
PMID 24167195
Citations 117
Authors
Affiliations
Soon will be listed here.
Abstract

Somatic heterozygous mutations of the DNA methyltransferase gene DNMT3A occur frequently in acute myeloid leukemia and other hematological malignancies, with the majority (∼60%) of mutations affecting a single amino acid, Arg882 (R882), in the catalytic domain. Although the mutations impair DNMT3A catalytic activity in vitro, their effects on DNA methylation in cells have not been explored. Here, we show that exogenously expressed mouse Dnmt3a proteins harboring the corresponding R878 mutations largely fail to mediate DNA methylation in murine embryonic stem (ES) cells but are capable of interacting with wild-type Dnmt3a and Dnmt3b. Coexpression of the Dnmt3a R878H (histidine) mutant protein results in inhibition of the ability of wild-type Dnmt3a and Dnmt3b to methylate DNA in murine ES cells. Furthermore, expression of Dnmt3a R878H in ES cells containing endogenous Dnmt3a or Dnmt3b induces hypomethylation. These results suggest that the DNMT3A R882 mutations, in addition to being hypomorphic, have dominant-negative effects.

Citing Articles

Using human disease mutations to understand de novo DNA methyltransferase function.

Rolls W, Wilson M, Sproul D Biochem Soc Trans. 2024; 52(5):2059-2075.

PMID: 39446312 PMC: 11555716. DOI: 10.1042/BST20231017.


Clonal hematopoiesis and hematological malignancy.

Dunn W, McLoughlin M, Vassiliou G J Clin Invest. 2024; 134(19).

PMID: 39352393 PMC: 11444162. DOI: 10.1172/JCI180065.


The Role of DNMT Methyltransferases and TET Dioxygenases in the Maintenance of the DNA Methylation Level.

Davletgildeeva A, Kuznetsov N Biomolecules. 2024; 14(9).

PMID: 39334883 PMC: 11430729. DOI: 10.3390/biom14091117.


Loss-of-function mutations in Dnmt3a and Tet2 lead to accelerated atherosclerosis and concordant macrophage phenotypes.

Rauch P, Gopakumar J, Silver A, Nachun D, Ahmad H, McConkey M Nat Cardiovasc Res. 2024; 2(9):805-818.

PMID: 39196062 DOI: 10.1038/s44161-023-00326-7.


The ICF syndrome protein CDCA7 harbors a unique DNA binding domain that recognizes a CpG dyad in the context of a non-B DNA.

Hardikar S, Ren R, Ying Z, Zhou J, Horton J, Bramble M Sci Adv. 2024; 10(34):eadr0036.

PMID: 39178265 PMC: 11343032. DOI: 10.1126/sciadv.adr0036.


References
1.
Yamashita Y, Yuan J, Suetake I, Suzuki H, Ishikawa Y, Choi Y . Array-based genomic resequencing of human leukemia. Oncogene. 2010; 29(25):3723-31. DOI: 10.1038/onc.2010.117. View

2.
Kim J, Lee S, Li L, Park H, Park J, Lee K . High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice. PLoS One. 2011; 6(4):e18556. PMC: 3084703. DOI: 10.1371/journal.pone.0018556. View

3.
Grossmann V, Haferlach C, Weissmann S, Roller A, Schindela S, Poetzinger F . The molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL. Genes Chromosomes Cancer. 2013; 52(4):410-22. DOI: 10.1002/gcc.22039. View

4.
Challen G, Sun D, Jeong M, Luo M, Jelinek J, Berg J . Dnmt3a is essential for hematopoietic stem cell differentiation. Nat Genet. 2011; 44(1):23-31. PMC: 3637952. DOI: 10.1038/ng.1009. View

5.
Stegelmann F, Bullinger L, Schlenk R, Paschka P, Griesshammer M, Blersch C . DNMT3A mutations in myeloproliferative neoplasms. Leukemia. 2011; 25(7):1217-9. DOI: 10.1038/leu.2011.77. View